Canada markets open in 2 hours 37 minutes

Panbela Therapeutics, Inc. (PBLA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.6700+0.0600 (+3.73%)
At close: 03:56PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    Panbela Provides Business Update and Reports Q1 2022 Financial Results

    MINNEAPOLIS, May 12, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, today provides a business update and reports financial results for the quarter ended March 31, 2022. Management is hosting an earnings call today at 4:30 p.m. ET. The first quarter was marked by meaningful progress. Q1 and Recent Highlights: Agreed to acquire Cancer Prevention Pharmaceuticals, Inc. (CPP). T

  • GlobeNewswire

    Panbela to Host Virtual R&D Day

    MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, will host an R&D call on Tuesday, May 03, 2022 at 9:00 AM Eastern Time. Panbela’s management team will be joined by leading experts for a deep dive on the company’s investigational drug, SBP-101, as a polyamine metabolism modulator in ovarian cancer. Conference Call Information Event Dat

  • GlobeNewswire

    Panbela Schedules Conference Call on May 12, 2022, to Report 2022 First Quarter Financial Results

    MINNEAPOLIS, April 26, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that it will host a conference call on May 12, 2022 at 4:30 PM Eastern Time to discuss results for its first quarter ended March 31, 2022. Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. Date: